Jagran Prakashan Ltd

Jagran Prakashan Ltd

₹ 83.9 1.17%
22 Nov - close price
About

Jagran Prakashan Ltd is a media conglomerate with interests spanning across printing and publication of newspapers & magazines, FM radio, digital, outdoor advertising and promotional marketing, event management and activation business.[1]

Key Points

A) Print Business Division
The company operates 10 different print titles across various categories. It has a presence across 13 states and UTs with 300+ editions/ sub-editions of its daily newsprints with a base of ~84 Mn readers. Its flagship newspaper Dainik Jagran is the largest Hindi daily newsprint and its Urdu paper Inquilab is the leading Urdu newspaper in India. [1] [2]

  • Market Cap 1,827 Cr.
  • Current Price 83.9
  • High / Low 130 / 82.0
  • Stock P/E 11.3
  • Book Value 87.4
  • Dividend Yield 5.96 %
  • ROCE 9.13 %
  • ROE 7.66 %
  • Face Value 2.00

Pros

  • Company has reduced debt.
  • Stock is trading at 0.96 times its book value
  • Stock is providing a good dividend yield of 5.96%.
  • Company has been maintaining a healthy dividend payout of 34.3%

Cons

  • The company has delivered a poor sales growth of -3.93% over past five years.
  • Company has a low return on equity of 8.23% over last 3 years.
  • Earnings include an other income of Rs.101 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
403 519 425 454 454 488 459 455 459 511 510 444 447
301 351 340 377 368 406 451 385 387 406 484 379 379
Operating Profit 101 168 85 77 86 82 9 69 72 105 25 66 68
OPM % 25% 32% 20% 17% 19% 17% 2% 15% 16% 20% 5% 15% 15%
18 18 17 13 19 60 53 22 18 27 24 23 27
Interest 8 8 8 8 10 10 11 7 6 6 8 6 5
Depreciation 30 30 30 28 27 26 26 27 27 28 29 26 27
Profit before tax 82 148 64 54 68 106 25 57 57 97 12 58 62
Tax % 25% 26% 17% 25% 25% 22% 8% 23% 27% 24% 51% 29% 33%
61 110 53 40 51 82 23 44 42 73 6 41 42
EPS in Rs 2.35 4.13 2.06 1.57 1.96 3.12 0.93 2.05 1.95 3.39 1.05 1.89 1.97
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,522 1,703 1,770 2,079 2,283 2,304 2,363 2,097 1,289 1,616 1,856 1,934 1,911
1,235 1,336 1,323 1,489 1,643 1,721 1,829 1,665 1,061 1,256 1,602 1,663 1,648
Operating Profit 286 366 446 590 640 583 534 433 228 360 254 271 263
OPM % 19% 22% 25% 28% 28% 25% 23% 21% 18% 22% 14% 14% 14%
125 53 112 94 41 47 41 32 42 73 145 90 101
Interest 31 35 37 55 35 27 26 33 34 31 39 28 25
Depreciation 126 79 104 122 129 136 128 146 129 119 107 111 110
Profit before tax 255 306 418 508 517 467 421 286 107 282 253 223 229
Tax % 0% 26% 26% 31% 32% 33% 35% 2% 27% 23% 22% 26%
255 226 308 351 349 311 274 281 78 217 197 165 162
EPS in Rs 7.69 6.92 9.42 10.73 10.63 9.63 8.79 9.72 3.19 8.44 7.58 8.44 8.30
Dividend Payout % 26% 58% 37% -0% 28% 31% 40% -0% -0% -0% 44% 59%
Compounded Sales Growth
10 Years: 1%
5 Years: -4%
3 Years: 14%
TTM: 3%
Compounded Profit Growth
10 Years: -3%
5 Years: -11%
3 Years: 27%
TTM: 1%
Stock Price CAGR
10 Years: -5%
5 Years: 8%
3 Years: 8%
1 Year: -14%
Return on Equity
10 Years: 12%
5 Years: 8%
3 Years: 8%
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 66 65 65 65 65 62 59 56 56 53 44 44 44
Reserves 869 899 1,071 1,566 2,090 1,977 1,816 1,862 1,940 2,085 1,704 1,885 1,860
484 490 648 591 308 148 406 281 318 352 443 247 204
381 471 469 442 748 785 814 738 648 653 739 652 824
Total Liabilities 1,801 1,925 2,253 2,664 3,212 2,972 3,096 2,938 2,961 3,142 2,930 2,827 2,931
778 791 773 1,422 1,492 1,476 1,493 1,455 1,346 1,269 1,068 908 903
CWIP 131 114 72 145 76 12 3 2 2 2 2 6 7
Investments 222 332 357 362 535 523 506 526 839 1,029 1,020 926 963
669 688 1,051 734 1,109 961 1,093 955 774 842 839 986 1,058
Total Assets 1,801 1,925 2,253 2,664 3,212 2,972 3,096 2,938 2,961 3,142 2,930 2,827 2,931

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
202 331 439 425 477 391 285 404 348 322 272 297
-164 -170 -441 156 -419 102 -58 37 -332 -204 249 28
-31 -188 17 -573 63 -605 -224 -462 -2 -123 -517 -307
Net Cash Flow 7 -28 15 7 121 -113 2 -21 15 -5 4 18

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 77 73 75 79 82 96 98 98 122 98 89 92
Inventory Days 56 60 54 39 52 36 84 113 64 72 60 38
Days Payable 70 76 66 48 82 73 82 107 114 122 111 128
Cash Conversion Cycle 62 57 63 69 53 59 100 104 72 48 38 2
Working Capital Days 41 44 5 50 33 70 73 82 81 57 41 49
ROCE % 19% 21% 22% 24% 21% 18% 17% 12% 5% 11% 8% 9%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
69.40% 69.40% 69.41% 69.42% 69.42% 69.00% 69.00% 69.00% 69.00% 69.00% 69.00% 69.00%
2.90% 3.13% 3.18% 3.12% 3.33% 3.39% 3.31% 3.34% 3.54% 3.05% 3.04% 2.48%
11.82% 11.14% 10.40% 10.44% 11.21% 11.48% 11.09% 11.21% 10.74% 10.61% 9.62% 9.12%
15.88% 16.33% 17.01% 17.01% 16.05% 16.13% 16.60% 16.45% 16.72% 17.33% 18.36% 19.43%
No. of Shareholders 46,15549,70650,00849,26747,51043,62342,82542,14143,29148,72650,93552,948

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls